Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Hagigit

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 6, 2011
Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and miceTal Hagigit, Muhammad Abdulrazik, Faty Valamanesh, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 3, 2008
The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsionsTal Hagigit, Taher Nassar, Francine Behar-Cohen, et al.
Journal of Toxicologic Pathology|February 25, 2021
Treatment of contaminated radial fracture in Sprague-Dawley rats by application of a degradable polymer releasing gentamicinYuval Ramot, Michal Steiner, Netanel Amouyal, et al.
Biomacromolecules|May 21, 2016
Alternating Poly(ester-anhydride) by Insertion PolycondensationMoran Haim-Zada, Arijit Basu, Tal Hagigit, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 30, 2016
Stable polyanhydride synthesized from sebacic acid and ricinoleic acidMoran Haim-Zada, Arijit Basu, Tal Hagigit, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2010
Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eyeTal Hagigit, Muhammad Abdulrazik, Faik Orucov, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 6, 2011
Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and miceTal Hagigit, Muhammad Abdulrazik, Faty Valamanesh, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 3, 2008
The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsionsTal Hagigit, Taher Nassar, Francine Behar-Cohen, et al.
Journal of Toxicologic Pathology|February 25, 2021
Treatment of contaminated radial fracture in Sprague-Dawley rats by application of a degradable polymer releasing gentamicinYuval Ramot, Michal Steiner, Netanel Amouyal, et al.
Biomacromolecules|May 21, 2016
Alternating Poly(ester-anhydride) by Insertion PolycondensationMoran Haim-Zada, Arijit Basu, Tal Hagigit, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 30, 2016
Stable polyanhydride synthesized from sebacic acid and ricinoleic acidMoran Haim-Zada, Arijit Basu, Tal Hagigit, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2010
Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eyeTal Hagigit, Muhammad Abdulrazik, Faik Orucov, et al.
Pageof 1